Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Nov 16;3(1):299-309.
doi: 10.3233/ADR-190152.

Diet Associated with Inflammation and Alzheimer's Disease

Affiliations
Review

Diet Associated with Inflammation and Alzheimer's Disease

Maryam Vasefi et al. J Alzheimers Dis Rep. .

Abstract

Neurocognitive disorders, such as Alzheimer's disease (AD), affect millions of people worldwide and are characterized by cognitive decline. Human and animal studies have shown that chronic immune response and inflammation are important factors in the pathogenesis of AD. Chronic inflammation can accelerate the aggregation of amyloid-β peptides and later hyperphosphorylation of tau proteins. The exact etiology of AD is not clear, but genetics and environmental factors, such as age, family history, and lifestyle are linked to neurodegenerative diseases. Lifestyle habits, such as poor diet, are associated with inflammation and could accelerate or slow down the progression of neurodegenerative diseases. Here we provide a review of the potential conditions and factors that stimulate the inflammatory processes in AD. An understanding of inflammatory mechanisms influencing the development of AD may help to protect against dementia and AD.

Keywords: Alzheimer’s disease; diet; gluten sensitivity; inflammation; microbiome; oxidative stress.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest to report.

Figures

Fig.1
Fig.1
Diet can accelerate Alzheimer’s disease progression throughout chronic inflammation.

Similar articles

Cited by

References

    1. Langa KM (2018) Future Directions for the Demography of Aging: Proceedings of a Workshop. National Academies Press (US), Washington DC. - PubMed
    1. Matyas N, Auer S, Gisinger C, Kil M, Keser Aschenberger F, Klerings I, Gartlehner G (2017) Continuing education for the prevention of mild cognitive impairment and Alzheimer’s-type dementia: A systematic review protocol. Syst Rev 6, 157. - PMC - PubMed
    1. Zissimopoulos J, Crimmins E, St Clair P (2014) The value of delaying Alzheimer’s disease onset. Forum Health Econ Policy 18, 25–39. - PMC - PubMed
    1. Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM, Herrup K, Frautschy SA, Finsen B, Brown GC, Verkhratsky A, Yamanaka K, Koistinaho J, Latz E, Halle A, Petzold GC, Town T, Morgan D, Shinohara ML, Perry VH, Holmes C, Bazan NG, Brooks DJ, Hunot S, Joseph B, Deigendesch N, Garaschuk O, Boddeke E, Dinarello CA, Breitner JC, Cole GM, Golenbock DT, Kummer MP (2015) Neuroinflammation in Alzheimer’s disease. Lancet Neurol 14, 388–405. - PMC - PubMed
    1. Heppner FL, Ransohoff RM, Becher B (2015) Immune attack: The role of inflammation in Alzheimer disease. Nat Rev Neurosci 16, 358–372. - PubMed

LinkOut - more resources